A substantive theory of quality of life of adults with chronic leukaemia

doi:10.1016/S0020-7489(96)00025-9

International Journal of Nursing Studies

Volume 34, Issue 1, February 1997, Pages 9-16

https://doi.org/10.1016/S0020-7489(96)00025-9 Get rights and content

Abstract

The person with chronic leukaemia is living with a chronic and life-threatening disease. The aims of this study were to gain a deeper understanding of what individuals with chronic leukaemia consider QOL to be and to give the concept of QOL a theoretical and empirical significance relevant to nursing care. Fifteen adults with different forms of diagnosed chronic leukaemia have been interviewed about their experience of QOL. Verbatim transcripts were analysed using constant comparative analysis. The emerging core category was life satisfaction. Under this construct there were four categories; self-esteem, interpersonal relationships, performance ability and social ability. Changed QOL was described in two ways. First, coping was the core category for living with chronic leukaemia. The strategies were action, denial and hope. Second, QOL was seen as individual perception, experience of a positive attitude to life and self-contemplation.

References (26)

L.L. Doane et al.
Hairy Cell Leukemia, current management
Hematol./Oncol. Clin. N. Am.
(1990)
T. Han et al.
Management of chronic lymphocytic leukemia
Hematol./Oncol. Clin. N. Am.
(1990)
M. Oleson
Content validity of the Quality of Life index
Appl. Nurs. Res.
(1990)
R.T. Silver
Chronic Myeloid Leukemia. A perspective of the clinical and biologic issues of the chronic phase
Hematol./Oncol. Clin. N. Am.
(1990)
E. Allardt
Having, Loving, Being. About Welfare in the Nordic Countries
(1980)
B.M. Babior et al.
C. Berterö et al.
Quality of life of adults with acute leukaemia
J. Adv. Nurs.
(1993)
F. van Dam et al.
Quality of life: some theoretical issues
J. clin. Pharmacol.
(1981)
L. Feigenberg
B.G. Glaser et al.

B.G. Glaser

H. Hagberg

Treatment with alpha-interferon has good effects on Hairy-Cell Leukaemia

Läkartidningen

(1986)

Cited by (35)

Validation of the transactional eHealth literacy instrument with cancer caregivers
2022, PEC Innovation
Family members are important sources of support for patients with cancer. They access, evaluate, and engage with online information and discuss it with a cancer clinician. This study validates the 4-dimensions, 18-item Transactional eHealth Literacy Instrument (TeHLI) and proposed to include Clinical eHealth Literacy as a 5th dimension.
The Leukemia & Lymphoma Society (LLS) disseminated an online survey to 121 family member caregivers between March-June 2020. We conducted confirmatory factor analyses (1) to examine model fit for the 4-factor TeHLI in the cancer caregiver population, and (2) to examine the model fit when adding the 5th factor.
The 4-dimension model yielded acceptable model fit (RMSEA = 0.09; 90% CI = 0.08-0.11; CFI = 0.98; TLI = 0.98; SRMR = 0.07). The 5-dimension model also yielded acceptable model fit (RMSEA = 0.08; 90% CI = 0.07-0.10; CFI = 0.97; TLI = 0.97; SRMR = 0.08), supporting the expansion of the TeHLI within this population.
The five-dimension TeHLI is a valid and reliable measure of eHealth literacy among blood cancer caregiver populations.
The TeHLI can be used as an outcome measure for communication skills training for caregivers, patients, and clinicians.
Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: Inclusion of quality of life and other patient-reported outcomes
2012, Critical Reviews in Oncology/Hematology
Citation Excerpt :
None of the studies identified were published before 1995 and 10 were published after 2000. Five studies were conducted in the USA [33,38,42,43,45], 5 in UK/Ireland [36,37,39,40,44], 2 in Sweden [34,35], 1 in Canada [41], 1 in Belgium [47] and one was performed in a variety of countries [46]. Overall 1998 CML patients were enrolled in these studies, however half of these (N = 1049) were part of a large international randomized controlled trial-RCT (IRIS study) [46].
Health-related quality of life (HRQOL) and other patient-reported outcomes (PROs) might be crucial in comparing effectiveness of treatments as they could provide invaluable information to better inform clinical decision-making. This is particularly true in the era of targeted therapies (TT). A systematic review was undertaken on all studies with CML patients published from 1980 to 2010 and including a PRO evaluation. Out of 619 articles scrutinized, 15 met eligibility criteria and no study was published before 1995. Six dealt mainly with interferon-based therapies, 7 with bone marrow transplantation and only 2 evaluated PROs in the context of TT. No disease-specific, validated PRO instrument for these patients was found. The main evidence being that Imatinib provides clear advantage in terms of HRQOL over interferon-based treatments. There is lack of data concerning PROs in patients treated with current TT. Documenting HRQOL and side effects of CML treatments, from the patients’ perspective is needed to evaluate overall treatment effectiveness and net clinical benefit of newer therapeutic strategies.
Research priorities in haemato-oncology nursing: Results of a literature review and a Delphi study
2009, European Journal of Oncology Nursing
The study aimed to review the nursing haemato-oncology literature followed by a Delphi study to determine research priorities of UK nurses working in haemato-oncology.
The review analysed relevant literature from 1996–2008. In the Delphi study, all members of the Royal College of Nursing (UK), Haematology and Bone Marrow Transplant Forum (n = 1444) were invited to participate. Data were collected in three sequential rounds of postal questionnaires. Research topics identified in round 1 were used to compile subsequent questionnaires.
A final list of 33 research priorities was identified. Clear research themes emerged from the data including chemotherapy, psychosocial issues and information giving, psychological support needs of nurses, ethical considerations and palliative care, nurse-led services and guidelines.
Results show both similarities and differences to priorities identified in previous haemopoietic stem cell transplant and cancer nursing studies. Further exploration of priority areas is required but priorities identified in this study provide a good starting point for further exploration and development of research programmes.
Coping with illness and subjective theories of illness in adult patients with haematological malignancies: Systematic review
2009, Critical Reviews in Oncology/Hematology
Citation Excerpt :
Survivors after a cytotoxic chemotherapy were interviewed once [71]. Four studies used bone marrow transplantation [72–75], one used autologous peripheral blood stem cell transplantation [79], and two studies did not give relevant details about treatment [76,77]. Patients with high-dose chemotherapy following isolation (without a statement regarding a possible BMT) were examined once [78].
In parallel to development of individualised antineoplastic treatment, scientific interest in patients’ subjective theories of illness (STOI) has emerged in the oncological community. STOI depend decisively on patients’ information about their disease. Coping with illness is dependent from the individual situation and context, and it is generally modulated by patients’ STOI. The purpose is fivefold: (1) to provide a thorough literature review about coping and about STOI in adult haematological patients, (2) to survey through which indicators the topics were operationalized in studies, (3) to clarify the kind of coherence between these two topics, (4) to explicate the interaction between STOI and other variables, and (5) to verify the clinical relevance of both topics. We searched 19 electronic databanks for English biomedical literature manuscripts (1995–2008) on this subject. Twenty-six studies met our criteria and varied in haematological entity, treatment concept, sample size and methodological design. We conclude that a subjective-individual regulation of patient’s mental stability during a cytotoxic chemotherapy is important. Successful coping strategies develop not only based on objective, but also subjective evaluation mechanisms. We deduce consequences for doctor–patient communication and psychosocial care in haematology. The newly developed process model of subjective regulation in cancer patients, in general, views the oncological treatment process as a procedural mental evaluation.
Assessing the quality of life of patients in phase I and II anti-cancer drug trials: Interviews versus questionnaires
2003, Social Science and Medicine
This paper discusses two different approaches to assessing quality of life in the context of cancer clinical trial participation. Drawing on empirical evidence from a study of patients’ experiences of phase I and II anti-cancer drug trial participation, the paper demonstrates how different methods of collecting data about an individual's quality of life (questionnaires and interviews) can lead to alternative conclusions about patients’ trial experience and the impact of trial involvement on their quality of life. Data obtained from the quality of life questionnaires interestingly revealed no statistically significant differences in any of the scores over time while in-depth interviews uncovered something of the psychological, emotional and social impact of taking part in a clinical trial from the perspective of the patient. The paper concludes by reflecting on some of the methodological issues that arise when assessing the quality of life of patients with a life threatening disease in clinical trials.
Living with a blood cancer in later life: The complex challenges and related support needs of adults aged 75 and older
2023, Palliative and Supportive Care

View all citing articles on Scopus

View full text

A substantive theory of quality of life of adults with chronic leukaemia

Abstract

Hematol./Oncol. Clin. N. Am.

Hematol./Oncol. Clin. N. Am.

Appl. Nurs. Res.

Hematol./Oncol. Clin. N. Am.

Having, Loving, Being. About Welfare in the Nordic Countries

Quality of life of adults with acute leukaemia

J. Adv. Nurs.

Quality of life: some theoretical issues

J. clin. Pharmacol.

Treatment with alpha-interferon has good effects on Hairy-Cell Leukaemia

Läkartidningen